Deciphering the Broad Antimicrobial Activity of Melaleuca alternifolia Tea Tree Oil by Combining Experimental and Computational Investigations
- PMID: 37569803
- PMCID: PMC10420022
- DOI: 10.3390/ijms241512432
Deciphering the Broad Antimicrobial Activity of Melaleuca alternifolia Tea Tree Oil by Combining Experimental and Computational Investigations
Abstract
Tea Tree Oil (TTO) is an essential oil obtained from the distillation of Melaleuca alternifolia leaves and branches. Due to its beneficial properties, TTO is widely used as an active ingredient in antimicrobial preparations for topical use or in cosmetic products and contains about 100 different compounds, with terpinen-4-ol, γ-terpinene and 1,8-cineole (or eucalyptol) being the molecules most responsible for its biological activities. In this work, the antimicrobial activity of whole TTO and these three major components was evaluated in vitro against fungi, bacteria and viruses. Molecular dynamics simulations were carried out on a bacterial membrane model and a Coxsackievirus B4 viral capsid, to propose an atomistic explanation of their mechanism of action. The obtained results indicate that the strong antimicrobial activity of TTO is attributable to the induction of an altered membrane functionality, mediated by the incorporation of its components within the lipid bilayer, and to a possible ability of the compounds to bind and alter the structural properties of the viral capsid.
Keywords: antifungal activity; antimicrobial activity; antiviral activity; eukaryotic cells viability; membrane partitioning; molecular docking; molecular dynamics; tea tree oil; viral capsid binders.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10420022/bin/ijms-24-12432-g001.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10420022/bin/ijms-24-12432-g002.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10420022/bin/ijms-24-12432-g003.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10420022/bin/ijms-24-12432-g004.gif)
![Figure 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10420022/bin/ijms-24-12432-g005.gif)
![Figure 6](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10420022/bin/ijms-24-12432-g006.gif)
Similar articles
-
In vitro antifungal activity of the tea tree (Melaleuca alternifolia) essential oil and its major components against plant pathogens.Lett Appl Microbiol. 2007 Jun;44(6):613-8. doi: 10.1111/j.1472-765X.2007.02128.x. Lett Appl Microbiol. 2007. PMID: 17576222
-
In vivo activity of terpinen-4-ol, the main bioactive component of Melaleuca alternifolia Cheel (tea tree) oil against azole-susceptible and -resistant human pathogenic Candida species.BMC Infect Dis. 2006 Nov 3;6:158. doi: 10.1186/1471-2334-6-158. BMC Infect Dis. 2006. PMID: 17083732 Free PMC article.
-
In Vitro Antimicrobial Activities of Commercially Available Tea Tree (Melaleuca alternifolia) Essential Oils.Curr Microbiol. 2019 Jan;76(1):108-116. doi: 10.1007/s00284-018-1594-x. Epub 2018 Nov 12. Curr Microbiol. 2019. PMID: 30421144
-
River Tea Tree Oil: Composition, Antimicrobial and Antioxidant Activities, and Potential Applications in Agriculture.Plants (Basel). 2021 Oct 4;10(10):2105. doi: 10.3390/plants10102105. Plants (Basel). 2021. PMID: 34685914 Free PMC article. Review.
-
Melaleuca alternifolia (tea tree) oil and its monoterpene constituents in treating protozoan and helminthic infections.Biomed Pharmacother. 2020 Oct;130:110624. doi: 10.1016/j.biopha.2020.110624. Epub 2020 Sep 2. Biomed Pharmacother. 2020. PMID: 33503761 Review.
Cited by
-
Coatings Based on Essential Oils for Combating Antibiotic Resistance.Antibiotics (Basel). 2024 Jul 4;13(7):625. doi: 10.3390/antibiotics13070625. Antibiotics (Basel). 2024. PMID: 39061307 Free PMC article. Review.
References
-
- Puvača N., Milenković J., Galonja Coghill T., Bursić V., Petrović A., Tanasković S., Pelić M., Ljubojević Pelić D., Miljković T. Antimicrobial Activity of Selected Essential Oils against Selected Pathogenic Bacteria: In Vitro Study. Antibiotics. 2021;10:546. doi: 10.3390/antibiotics10050546. - DOI - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources